Exhibit B.docx

19 KB Posted

Attached to
Pre-filled Syringes and Bags for Naval Medical Center Portsmouth
Solicitation number
HT940625QE012
Issued by

About this file

Written by GovTribe AI ·

Exhibit B is a detailed pricing and product specification document for a pre-filled syringes and bags contract with the Defense Health Agency (DHA) for Naval Medical Center Portsmouth. The document lists 24 FDA-approved medications with specific National Drug Codes, including detailed specifications such as drug concentration, volume, and maximum annual quantity. Key medications include Hydromorphone, Ketamine, Fentanyl, Midazolam, Morphine Sulfate, Norepinephrine, and various other injectable solutions, with annual quantities ranging from 20 to 4,640 units per medication type.

The contract is a Firm Fixed Price (FFP) Indefinite Delivery/Indefinite Quantity (IDIQ) supply contract covering commercial items under simplified acquisition procedures. The performance period is specified as 01 October 2026 - 30 September 2027, with unit pricing for each medication type. Vendors are required to submit proposals following specific guidelines outlined in the Instructions to Offerors and Evaluation Factors For Award sections of the SF1449 form, targeting the pharmacy department at Naval Medical Center Portsmouth.

View the file

Other files

File Type Posted
Solicitation - HT940625QE012 0001.pdf PDF
Attachment 2- Past Performance Questionnaire.docx DOCX document
Attachment 1 Project Summary Sheet.docx DOCX document
Exhibit D.docx DOCX document
Exhibit E.docx DOCX document
Exhibit C.docx DOCX document
Attachment 2 Past Performance Questionnaire.docx DOCX document
Exhibit A.docx DOCX document
Solicitation - HT940625QE012.pdf PDF

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file
Try for free Login

Text version

The file's text, extracted by GovTribe without its formatting.

Exhibit B- POP 01 October 2026 – 30 September 2027 FDA Approved Medications

National Drug Code
Description
Max Annual Quantity
Unit Price
71266-9015-03
Fagron Glycopyrrolate 0.2mg/mL 0.6mg
300
71266-9027-01
Ephedrine Sulfate 5mg/mL (25mg/5mL) 5mL Syringe
200
71266-9110-03
Hydromorphone HCl 0.2mg/mL 30mL
1,000
71266-9080-02
Ketamine 10mg/mL (API) 5mL Fill in 5mL Syringe
864
71266-2003-02
Neostigmine Methylsulfate 1mg/mL (API) 5mL
580
71266-9032-01
PHENYLephrine 0.04mg/mL PF Inj Soln 10mL Syringe
300
71266-9011-01
PHENYLephrine 0.1mg/mL PF Inj Soln 10mL Syringe
400
71266-2002-01
Rocuronium Bromide Inj. 10mg/mL (API) 5mL
4,640
71266-2001-01
SUCCINYLcholine Chl. Inj. USP 100mg/5mL (20mg/mL)
864
71266-9090-01
Lidocaine HCl 2% 20mg/mL Sol for Inj. PF 5mL
864
71266-9228-01
Fentanyl Citrate 2mcg/mL Bupivacaine HCl 0.125% 100mL IV Bag
300
71266-9227-01
Fentanyl Citrate 2mcg/mL Bupivacaine HCl 0.125% 250mL IV Bag
2,000
71266-9225-01
Fentanyl Citrate 2mcg/mL Bupivacaine HCl 0.0625% 250mL IV Bag
50
71266-9190-06
Midazolam 1mg/mL 50mL Fill, 50mL syringe API
152
71266-5030-01
Midazolam 1mg/mL (100mg/100mL) 100mL in 100mL Bag
152
71266-5030-02
Midazolam 1mg/mL (50mg/50mL) 50mL in 100mL Bag
152
71266-6290-01
Lidocaine HCl 4% EPINEPHrine Bitartrate 0.18% tetracaine HCl 0.5% Sterile Topical Gel, 5mL syringe, 3mL Fill
152
71266-6286-03
Lidocaine 4% EPINEPHrine 0.05% tetracaine 0.5% Topical Solution, 5mL syringe, 3mL Fill
152
71266-5100-01
Fagron Oxytocin 30U Inj Sol 500ml in 500mL Bag
2,752
71449-018-32
Hydromorphone 1 mg/mL, 30mL in 50mL Syringe
72
71449-022-32
Morphine Sulfate 5 mg/mL, PF, 30 mL in 50 mL Syringe
864
71266-9115-01
Hydromorphone HCl 1mg/mL 30mL Fill, 30mL Syr, API
72
71266-0712-01
70% Dextrose Injection Solution in 50mL Vial
400
71266-5026-02
Norepinephrine 16mg 250mL 0.9% NaCl IV Bag S2S
50
71506-032-58
Norepinephrine 32mg Bag
20
71266-2010-01
Atropine 0.4mg/1mL Sol for Inj 2mL fill 3mL Syr.
400

File details come from the government source that posted it. Updated .